JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1451
Travere Therapeutics
TVTX
$5.42B
| $25.5M | ﹤0.01% |
1,134,151
-88,807
| -7% | -$1.89M |
2016 Q4
25 quarters
|
|
1452
Stanley Black & Decker
SWK
$13.6B
| $25.4M | ﹤0.01% |
315,752
-340,425
| -52% | -$28.7M |
2013 Q2
39 quarters
|
|
1453
Kulicke & Soffa
KLIC
$5.22B
| $25.4M | ﹤0.01% |
482,645
+167,669
| +53% | +$8.72M |
2013 Q2
39 quarters
|
|
1454
Prosperity Bancshares
PB
$8.12B
| $25.4M | ﹤0.01% |
413,296
+122,378
| +42% | +$8.71M |
2013 Q2
39 quarters
|
|
1455
CALL
Expedia Group
EXPE
$31.6B
| $25.4M | ﹤0.01% |
262,000
+119,200
| +83% | +$12.5M |
2021 Q1
8 quarters
|
|
1456
iShares MSCI USA Value Factor ETF
VLUE
$9.51B
| $25.4M | ﹤0.01% |
274,334
-210,834
| -43% | -$19.8M |
2015 Q4
29 quarters
|
|
1457
WisdomTree US LargeCap Dividend Fund
DLN
$6.2B
| $25.4M | ﹤0.01% |
410,576
+193,335
| +89% | +$12M |
2015 Q4
29 quarters
|
|
|
TGNA
1458
DELISTED
TEGNA Inc
TGNA
| $25.3M | ﹤0.01% |
1,498,594
+573,807
| +62% | +$10.7M |
2013 Q2
39 quarters
|
|
1459
ICL Group
ICL
$6.52B
| $25.3M | ﹤0.01% |
3,724,591
+975,801
| +35% | +$7.2M |
2014 Q3
34 quarters
|
|
1460
Vanguard FTSE All-World ex-US ETF
VEU
$69.1B
| $25.3M | ﹤0.01% |
472,938
-4,093,467
| -90% | -$217M |
2013 Q2
39 quarters
|
|
1461
Sabra Healthcare REIT
SBRA
$4.91B
| $25.3M | ﹤0.01% |
2,196,922
+148,480
| +7% | +$1.84M |
2015 Q3
30 quarters
|
|
1462
American States Water
AWR
$3.23B
| $25.1M | ﹤0.01% |
282,325
+42,222
| +18% | +$3.86M |
2013 Q2
39 quarters
|
|
1463
Qualys
QLYS
$6.8B
| $25.1M | ﹤0.01% |
192,915
+12,077
| +7% | +$1.42M |
2014 Q2
35 quarters
|
|
1464
iShares US Healthcare ETF
IYH
$3.92B
| $25M | ﹤0.01% |
458,605
+29,495
| +7% | +$1.62M |
2013 Q2
39 quarters
|
|
|
NOVA
1465
DELISTED
Sunnova Energy
NOVA
| $25M | ﹤0.01% |
1,603,089
+1,069,764
| +201% | +$18.7M |
2019 Q3
14 quarters
|
|
1466
Intellia Therapeutics
NTLA
$1.73B
| $25M | ﹤0.01% |
671,132
+8,515
| +1% | +$334K |
2017 Q4
21 quarters
|
|
1467
Vanguard Long-Term Treasury ETF
VGLT
$9.87B
| $25M | ﹤0.01% |
381,656
+191,400
| +101% | +$12.3M |
2019 Q2
15 quarters
|
|
1468
First Trust NASDAQ-100 Technology Index Fund
QTEC
$4.15B
| $24.9M | ﹤0.01% |
190,935
+132,774
| +228% | +$15.9M |
2022 Q2
3 quarters
|
|
1469
iShares MSCI Chile ETF
ECH
$969M
| $24.9M | ﹤0.01% |
865,450
+292,874
| +51% | +$8.28M |
2022 Q2
3 quarters
|
|
1470
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$19.4B
| $24.9M | ﹤0.01% |
127,716
-242
| -0.2% | -$46.3K |
2015 Q4
29 quarters
|
|
1471
Allogene Therapeutics
ALLO
$511M
| $24.8M | ﹤0.01% |
5,024,544
+1,254,261
| +33% | +$8.04M |
2018 Q4
17 quarters
|
|
1472
Unum
UNM
$14.2B
| $24.8M | ﹤0.01% |
626,272
+95,426
| +18% | +$3.94M |
2013 Q2
39 quarters
|
|
1473
Trimble
TRMB
$13.8B
| $24.8M | ﹤0.01% |
472,156
+60,035
| +15% | +$3.2M |
2013 Q2
39 quarters
|
|
1474
Gerdau
GGB
$10.1B
| $24.6M | ﹤0.01% |
5,991,626
+329,046
| +6% | +$1.47M |
2013 Q2
39 quarters
|
|
1475
Olin
OLN
$1.86B
| $24.6M | ﹤0.01% |
443,317
-45,931
| -9% | -$2.63M |
2013 Q2
39 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.